- Hetero acquires Johnson & Johnson's Telangana plant 26 October 2022
- And now, formaldehyde found in J&J's baby shampoo 01 April 2019
- J&J told to stop using its baby powder raw material in India 21 December 2018
- Indian drug regulator may revive probe to J&J's baby powder: Reuters 18 December 2018
- J&J may have to pay up to Rs1.23 cr for defective hip implant 30 November 2018
- Pfizer, J&J in legal battle that could shape biosimilars market 21 September 2017
- Johnson & Johnson in talks to buy commercial portfolio of Actelion 30 December 2016
- Johnson & Johnson resumes merger talks with Actelion Pharmaceuticals 26 December 2016
- Actelion in exclusive negotiations with J&J after talks with Sanofi 22 December 2016
- J&J being sued over Risperidal causing breasts in men 16 December 2016
- Actelion says J&J backs off, in talks with another suitor 14 December 2016
- Johnson & Johnson ordered to pay $1.04 bn over faulty hip implants 02 December 2016
- Johnson & Johnson in talks to buy Swiss biotechnology firm Actelion 25 November 2016
- Another woman files case against Johnson & Johnson talc 27 September 2016
- J&J loses rheumatic drug patent battle; boost for Pfizer 18 August 2016
- J&J to acquire dermocosmetics products maker NeoStrata 27 April 2016
- J&J must pay $72 mn damages in talc case 25 February 2016
- Johnson & Johnson to cut 3,000 jobs in its medical devices unit 20 January 2016
- J&J launches clinical trial of preventive Ebola vaccine regimen 09 October 2015
- ITC to acquire J&J's Savlon, Shower to Shower brands in India 13 February 2015
- Mis-selling of drugs to cost J&J $2.2 bn in US settlement 05 November 2013
- PE firms in race for J&J's Ortho Clinical Diagnostics unit 01 October 2013
- J&J launches sale of Ortho Clinical Diagnostics unit 07 September 2013
- Johnson & Johnson weighs sale of Women's Health division: report 28 January 2013
- Rejected in the US, J&J sells hip implant overseas 16 February 2012
- J&J unit wins lawsuit over antibiotic Levaquin drug side effects 15 October 2011
- Merck & Co sells OTC joint venture to Johnson & Johnson for $175 million 29 September 2011
- Johnson & Johnson recalls anaemia drug Eprex in 17 countries 24 September 2011
- J&J may buy Synthes in $20-bn deal 16 April 2011
- Johnson & Johnson mulls fresh assault on Smith & Nephew: report 17 January 2011
- J&J's McNeil unit recalls over 13 million packets of Rolaids 10 December 2010
- J&J recalls Benadryl, Motrin 23 November 2010
- J&J issues sixth Tylenol recall since November 2009 20 October 2010
- Johnson & Johnson in talks to buy Crucell for $2.3 billion 17 September 2010
- J&J issues global recall for 1 Day Acuvue contact lenses 24 August 2010
- Johnson & Johnson recalls 43 children's drugs 03 May 2010
- Boston Scientific to pay J&J $1.73 billion in patent settlement 02 February 2010
- J&J adds several popular brands to Tylenol recall lots 16 January 2010
- US justice dept hauls J&J to court for paying kickbacks 16 January 2010
- J&J to buy ENT device maker Acclarent for $785 million 17 December 2009
- J&J to axe more than 7,000 jobs in restructuring 04 November 2009
- Boston Scientific and Johnson & Johnson settle patent disputes 30 September 2009
- J&J buys breast implant maker Mentor Corp for $1.07 billion 01 December 2008
- Tata's Advinus Therapeutics, J&J arm in drug development pact 01 October 2008
- Johnson & Johnson Nordic AB acquires Åmic 23 June 2008
- Boston Scientific beats J&J to acquire Guidant for $27 billion 25 January 2006
- Johnson & Johnson launches the stent war 29 March 2005
- FDA hauls up Johnson & Johnson on 'baby' branding 17 March 2005
- Johnson & Johnson close to acquiring Alza 27 March 2001
- Johnson & Johnson Ltd. 24 November 1999
- J&J hives off adhesives unit to Premchand group 12 August 1999
